Did Rubedo’s experimental drug really make skin two years younger? Phase 1b data reveal a surprising signal
Rubedo's RLS-1496 reduces measured skin epigenetic age by 2.1 years in early research, but clinical benefits remain to be proven.
Pharma & Biotech